Literature DB >> 22146601

Year in review 2010: Critical Care--Multiple organ dysfunction and sepsis.

Etienne de Montmollin1, Djillali Annane.   

Abstract

This review summarizes new insights in the pathophysiologic implications of inflammation and microvascular alterations in organ dysfunction, as well as genetic factor contribution, from clinical and experimental studies that were published in 2010 in Critical Care in the fields of multiple organ dysfunction and sepsis. New diagnostic and prognostic markers of organ dysfunction are presented. Evaluations of novel therapeutic strategies, including implementation of international guidelines, modulation of inflammation and coagulation, and prevention of ventilator-induced lung injury and acute kidney injury, are reported. The results of these experimental studies and clinical trials are discussed in the context of the current relevant scientific and clinical background.

Entities:  

Mesh:

Year:  2011        PMID: 22146601      PMCID: PMC3388699          DOI: 10.1186/cc10359

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


  38 in total

1.  Intensive insulin therapy in critically ill patients.

Authors:  G van den Berghe; P Wouters; F Weekers; C Verwaest; F Bruyninckx; M Schetz; D Vlasselaers; P Ferdinande; P Lauwers; R Bouillon
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

2.  Intensive versus conventional glucose control in critically ill patients.

Authors:  Simon Finfer; Dean R Chittock; Steve Yu-Shuo Su; Deborah Blair; Denise Foster; Vinay Dhingra; Rinaldo Bellomo; Deborah Cook; Peter Dodek; William R Henderson; Paul C Hébert; Stephane Heritier; Daren K Heyland; Colin McArthur; Ellen McDonald; Imogen Mitchell; John A Myburgh; Robyn Norton; Julie Potter; Bruce G Robinson; Juan J Ronco
Journal:  N Engl J Med       Date:  2009-03-24       Impact factor: 91.245

3.  Efficacy and safety of recombinant human activated protein C for severe sepsis.

Authors:  G R Bernard; J L Vincent; P F Laterre; S P LaRosa; J F Dhainaut; A Lopez-Rodriguez; J S Steingrub; G E Garber; J D Helterbrand; E W Ely; C J Fisher
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

4.  Is worsening multiple organ failure the cause of death in patients with severe sepsis?

Authors:  Jean-Louis Vincent; David R Nelson; Mark D Williams
Journal:  Crit Care Med       Date:  2011-05       Impact factor: 7.598

5.  Organ failure and tight glycemic control in the SPRINT study.

Authors:  J Geoffrey Chase; Christopher G Pretty; Leesa Pfeifer; Geoffrey M Shaw; Jean-Charles Preiser; Aaron J Le Compte; Jessica Lin; Darren Hewett; Katherine T Moorhead; Thomas Desaive
Journal:  Crit Care       Date:  2010-08-12       Impact factor: 9.097

6.  Cerebral microcirculation is impaired during sepsis: an experimental study.

Authors:  Fabio Silvio Taccone; Fuhong Su; Charalampos Pierrakos; Xinrong He; Syril James; Olivier Dewitte; Jean-Louis Vincent; Daniel De Backer
Journal:  Crit Care       Date:  2010-07-28       Impact factor: 9.097

7.  A prospective, observational study of soluble FLT-1 and vascular endothelial growth factor in sepsis.

Authors:  Nathan I Shapiro; Kiichiro Yano; Hitomi Okada; Christopher Fischer; Michael Howell; Katherine C Spokes; Long Ngo; Derek C Angus; William C Aird
Journal:  Shock       Date:  2008-04       Impact factor: 3.454

8.  Elevated serum angiopoietin 2 levels are associated with increased mortality in sepsis.

Authors:  Jonathan M Siner; Vineet Bhandari; Kathryn M Engle; Jack A Elias; Mark D Siegel
Journal:  Shock       Date:  2009-04       Impact factor: 3.454

9.  The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis.

Authors:  Nathan I Shapiro; Philipp Schuetz; Kiichiro Yano; Midori Sorasaki; Samir M Parikh; Alan E Jones; Stephen Trzeciak; Long Ngo; William C Aird
Journal:  Crit Care       Date:  2010-10-13       Impact factor: 9.097

10.  Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study.

Authors:  Jesús Blanco; Arturo Muriel-Bombín; Víctor Sagredo; Francisco Taboada; Francisco Gandía; Luís Tamayo; Javier Collado; Angel García-Labattut; Demetrio Carriedo; Manuel Valledor; Martín De Frutos; María-Jesús López; Ana Caballero; José Guerra; Braulio Alvarez; Agustín Mayo; Jesús Villar
Journal:  Crit Care       Date:  2008-12-17       Impact factor: 9.097

View more
  13 in total

Review 1.  Acute Inflammation and Metabolism.

Authors:  Miguel Lourenço Varela; Mihail Mogildea; Ignacio Moreno; Ana Lopes
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

2.  Unveiling differentially expressed genes upon regulation of transcription factors in sepsis.

Authors:  Junli Zhang; Yuelei Cheng; Minmin Duan; Nannan Qi; Jian Liu
Journal:  3 Biotech       Date:  2017-04-25       Impact factor: 2.406

Review 3.  [Procalcitonin as a  tool for the assessment of successful therapy of severe sepsis : An analysis using clinical routine data].

Authors:  K F Bodmann; M Schenker; W Heinlein; M H Wilke
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-07-04       Impact factor: 0.840

4.  Endothelial adhesion molecules and multiple organ failure in patients with severe sepsis.

Authors:  Bravein Amalakuhan; Sheila A Habib; Mandeep Mangat; Luis F Reyes; Alejandro H Rodriguez; Cecilia A Hinojosa; Nilam J Soni; Ryan P Gilley; Carlos A Bustamante; Antonio Anzueto; Stephanie M Levine; Jay I Peters; Stefano Aliberti; Oriol Sibila; James D Chalmers; Antoni Torres; Grant W Waterer; Ignacio Martin-Loeches; Jose Bordon; Jose Blanquer; Francisco Sanz; Pedro J Marcos; Jordi Rello; Julio Ramirez; Jordi Solé-Violán; Carlos M Luna; Charles Feldman; Martin Witzenrath; Richard G Wunderink; Daiana Stolz; Tim L Wiemken; Yuichiro Shindo; Charles S Dela Cruz; Carlos J Orihuela; Marcos I Restrepo
Journal:  Cytokine       Date:  2016-10-01       Impact factor: 3.861

Review 5.  In silico modeling: methods and applications to trauma and sepsis.

Authors:  Yoram Vodovotz; Timothy R Billiar
Journal:  Crit Care Med       Date:  2013-08       Impact factor: 7.598

6.  Peroxisome proliferator-activated receptor-γ activation prevents sepsis-related cardiac dysfunction and mortality in mice.

Authors:  Konstantinos Drosatos; Raffay S Khan; Chad M Trent; Hongfeng Jiang; Ni-Huiping Son; William S Blaner; Shunichi Homma; P Christian Schulze; Ira J Goldberg
Journal:  Circ Heart Fail       Date:  2013-04-09       Impact factor: 8.790

7.  Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsis.

Authors:  Pengfei Li; Youming Guo; Grant Bledsoe; Zhi-Rong Yang; Hongkuan Fan; Lee Chao; Julie Chao
Journal:  Crit Care       Date:  2015-05-01       Impact factor: 9.097

Review 8.  Lysosome and Cytoskeleton Pathways Are Robustly Enriched in the Blood of Septic Patients: A Meta-Analysis of Transcriptomic Data.

Authors:  Jie Ma; Chuanxi Chen; Andreas S Barth; Chris Cheadle; Xiangdong Guan; Li Gao
Journal:  Mediators Inflamm       Date:  2015-04-30       Impact factor: 4.711

9.  Diagnostic and Predictive Levels of Calcium-binding Protein A8 and Tumor Necrosis Factor Receptor-associated Factor 6 in Sepsis-associated Encephalopathy: A Prospective Observational Study.

Authors:  Li-Na Zhang; Xiao-Hong Wang; Long Wu; Li Huang; Chun-Guang Zhao; Qian-Yi Peng; Yu-Hang Ai
Journal:  Chin Med J (Engl)       Date:  2016-07-20       Impact factor: 2.628

10.  Why do they die? Comparison of selected aspects of organ injury and dysfunction in mice surviving and dying in acute abdominal sepsis.

Authors:  Susanne Drechsler; Katrin M Weixelbaumer; Adelheid Weidinger; Pierre Raeven; Anna Khadem; Heinz Redl; Martijn van Griensven; Soheyl Bahrami; Daniel Remick; Andrey Kozlov; Marcin F Osuchowski
Journal:  Intensive Care Med Exp       Date:  2015-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.